Imai Yoichi 今井陽一

… Alternative Names

IMAI YOICHI 今井陽一

IMAI Yoichi 今井陽一

今井陽一イマイヨウイチ

Less

Researcher Number	10345209
Other IDs
Affiliation (Current)	2025: 獨協医科大学, 医学部, 教授
Affiliation (based on the past Project Information) *help	2021 – 2024: 獨協医科大学, 医学部, 教授 2017 – 2021: 東京大学, 医科学研究所, 准教授 2011 – 2013: 東京女子医科大学, 医学部, 講師 2004: 東大, 医学部附属病院, 助手 2003: 東京大学, 医学部附属病院, 助手
Review Section/Research Field	Principal Investigator Hematology / Basic Section 54010:Hematology and medical oncology-related Except Principal Investigator Medium-sized Section 90:Biomedical engineering and related fields / Broad Section D
Keywords	Principal Investigator HDAC阻害剤 / 多発性骨髄腫 / DNAM-1 / CD112 / CD155 / TIGIT / AML / AKT / 抗体療法 / NK細胞 … More / 治療抵抗性 / 免疫チェックポイント / FLT3 / レナリドミド / セレブロン / CUDC-907 / HDAC阻害薬 / HDAC / NK-92 / Acute myeloid leukemia / Akt inhibitor / HDAC inhibitor / MM / CD155/CD112 / 癌 / 内科 / MICA / IKZF1 / GSK-3 / NKG2D / ADCC / AKT阻害 / HDAC阻害 / アポトーシス / 増殖抑制 / HOXA9 / CXCR4 / インテグリン / 国際情報交換 / カルシニューリン / 接着分子 / 血液腫瘍学 / プロテオミクス / P300 / アセチル化 / mSin3A / リン酸化 / 蛋白質修飾 / AML1 / 転写因子 … More Except Principal Investigator シンチレータ / 核医学 / SPECT / コンプトンカメラ / PET / 放射線 Less

DNAM-1/TIGIT/CD155/CD112を標的としたAMLに対する免疫療法の開発Principal Investigator
- Principal Investigator
  
  今井陽一
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Dokkyo Medical University
Strategy to overcome the refractoriness of hematological malignancies through inhibition of intracellular signaling and immune enhancementPrincipal Investigator
- Principal Investigator
  
  Imai Yoichi
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Dokkyo Medical University
  The University of Tokyo
Whole gamma imaging to break through the physical limitation of positron emission tomography
- Principal Investigator
  
  山谷泰賀
- Project Period (FY)
  2020 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (S)
- Review Section
  
  Broad Section D
- Research Institution
  National Institutes for Quantum Science and Technology
Zr-89 PETの物理限界を克服する全ガンマ線イメージング法の開発
- Principal Investigator
  
  山谷泰賀
- Project Period (FY)
  2020
- Research Category
  
  Grant-in-Aid for Scientific Research (A)
- Review Section
  
  Medium-sized Section 90:Biomedical engineering and related fields
- Research Institution
  National Institutes for Quantum and Radiological Science and Technology
Optimization of treatment for multiple myeloma with HDAC inhibitorsPrincipal Investigator
- Principal Investigator
  
  IMAI YOICHI
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  The University of Tokyo
Molecular mechanism of refractoriness of myeloma mediated by adhesion moleculesPrincipal Investigator
- Principal Investigator
  
  IMAI Yoichi
- Project Period (FY)
  2011 – 2013
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Tokyo Women's Medical University
プロテオミクスによる白血病関連転写因子AML1の機能制御機構の網羅的解析Principal Investigator
- Principal Investigator
  
  今井陽一
- Project Period (FY)
  2003 – 2004
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Hematology
- Research Institution
  The University of Tokyo

All 2023 2022 2021 2020 2019 2018 2017 2014 2013 2012 2011

All Journal Article Presentation Book

[Book] 多発性骨髄腫の診療指針　第5版　日本骨髄腫学会編　IV治療　6維持療法2020
- Author(s)
  今井　陽一
- Total Pages
  6
- Publisher
  文光堂
- ISBN
  9784830620614
- Data Source
  KAKENHI-PROJECT-20H05667
[Book] Heat Shock Proteins in Signaling Pathways, Heat Shock Proteins 172019
- Author(s)
  Imai Y, and Tojo A
- Total Pages
  600
- Publisher
  Springer
- Data Source
  KAKENHI-PROJECT-17K09916
[Book] 多発性骨髄腫発生病理とmixed-lineage leukemia (MLL)タンパク2014
- Author(s)
  今井陽一、太田瑛里
- Publisher
  日本臨床第72巻・第6号
- Data Source
  KAKENHI-PROJECT-23591409
[Book] 症例から学ぶメディカルオンコロジー2011
- Author(s)
  今井陽一、三橋健次郎、泉二登志子
- Total Pages
  8
- Publisher
  医薬ジャーナル社
- Data Source
  KAKENHI-PROJECT-23591409
[Journal Article] Hyperactive Natural Killer cells in Rag2 knockout mice inhibit the development of acute myeloid leukemia2023
- Author(s)
  Sugimoto Emi、Saito Takeshi、Yoshida Taku、Yamazaki Satoshi、Kaito Yuta、Imai Yoichi、Denda Tamami、Ota Yasunori、Fukuyama Tomofusa、Tanaka Yosuke、Enomoto Yutaka、Kitamura Toshio、Goyama Susumu
- Journal Title
  
  Communications Biology
  
  Volume: 6 Issue: 1 Pages: 1294-1294
- DOI
  10.1038/s42003-023-05606-3
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K07868, KAKENHI-PROJECT-22K19540, KAKENHI-PROJECT-23K24360
[Journal Article] Progression to B acute lymphoblastic leukemia in 8p11 myeloproliferative syndrome with t(6;8)(q27;p12)2023
- Author(s)
  Nakamura F, Seo S, Nannya Y, Ayabe R, Takahashi W, Handa T, Arai H, Iso H, Nakamura Y, Nakamura Y, Sasaki K, Ichikawa M, Imai Y, Ogawa S, Mitani K.
- Journal Title
  
  International Journal of Hematology
  
  Volume: - Issue: 3 Pages: 388-393
- DOI
  10.1007/s12185-023-03577-z
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20H05667, KAKENHI-PROJECT-20K08726, KAKENHI-PROJECT-23K07868
[Journal Article] Serum soluble CD86 levels correlate with CD86 variant 3 gene expression and are prognostic indicators in myeloma2023
- Author(s)
  Kinoshita R, Ishibashi M, Handa H, Sasaki M, Imai Y, Tanaka N, Ito S, Sunakawa-Kii M, Kaito Y, Asayama T, Komatsu N, Tanaka J, Odajima T, Sugimori H, Yamaguchi H, Inokuchi K, Tamura H.
- Journal Title
  
  Experimental Hematology
  
  Volume: 121 Pages: 38-48
- DOI
  10.1016/j.exphem.2023.01.006
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20H05667, KAKENHI-PROJECT-20K08726, KAKENHI-PROJECT-20K02658, KAKENHI-PROJECT-23K07868
[Journal Article] Current and Future PET Imaging for Multiple Myeloma.2023
- Author(s)
  Ishibashi M, Takahashi M, Yamaya T, Imai Y.
- Journal Title
  
  Life
  
  Volume: 13 Issue: 8 Pages: 1701-1715
- DOI
  10.3390/life13081701
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K07031, KAKENHI-PROJECT-20H05667
[Journal Article] Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for NK-cell therapy in acute myeloid leukemia2023
- Author(s)
  Kaito Yuta、Sugimoto Emi、Nakamura Fumi、Tsukune Yutaka、Sasaki Makoto、Yui Shunsuke、Yamaguchi Hiroki、Goyama Susumu、Nannya Yasuhito、Mitani Kinuko、Tamura Hideto、Imai Yoichi
- Journal Title
  
  Haematologica
  
  Volume: 109 Pages: 1107-1120
- DOI
  10.3324/haematol.2023.282915
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K07868, KAKENHI-PROJECT-20H05667
[Journal Article] CD155 and CD112 as possible therapeutic targets of FLT3 inhibitors for acute myeloid leukemia2022
- Author(s)
  Kaito Y, Hirano M, Futami M, Nojima M, Tamura H, Tojo A, Imai Y.
- Journal Title
  
  Oncology Letters
  
  Volume: 23 Issue: 2 Pages: 51-51
- DOI
  10.3892/ol.2021.13169
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20H05667, KAKENHI-PROJECT-20K08726
[Journal Article] RUNX1 transactivates BCR‐ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia2021
- Author(s)
  Masuda Tatsuya、Maeda Shintaro、Shimada Sae、Sakuramoto Naoya、Morita Ken、Koyama Asami、Suzuki Kensho、Mitsuda Yoshihide、Matsuo Hidemasa、...、Kamikubo Yasuhiko
- Journal Title
  
  Cancer Science
  
  Volume: 113 Issue: 2 Pages: 529-539
- DOI
  10.1111/cas.15239
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K16832, KAKENHI-PROJECT-20H05667, KAKENHI-PROJECT-20H00528, KAKENHI-PROJECT-20H03517, KAKENHI-PROJECT-20K08756, KAKENHI-PROJECT-21K06909, KAKENHI-PROJECT-21K19353, KAKENHI-PROJECT-21K19405, KAKENHI-PROJECT-20K08726
[Journal Article] Expression of activated integrin β7 in multiple myeloma patients2021
- Author(s)
  Hosen N, Yoshihara S, Takamatsu H, Ri M, Nagata Y, Kosugi H, Shimomura Y, Hanamura I, Fuji S, Minauchi K, Kuroda J, Suzuki R, Nishimura N, Uoshima N, Nakamae H, Kawano Y, Mizuno I, Gomyo H, Suzuki K, Ozaki S, Nakamura S, Imai Y, Kizaki M, Negoro E, Handa H, Iida S
- Journal Title
  
  International Journal of Hematology
  
  Volume: 114 Issue: 1 Pages: 3-7
- DOI
  10.1007/s12185-021-03162-2
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20H05667
[Journal Article] RUNX inhibitor suppresses graft‐versus‐host disease through targeting RUNX‐NFATC2 axis2021
- Author(s)
  Kubota Hirohito、Masuda Tatsuya、Noura Mina、Furuichi Kana、Matsuo Hidemasa、Hirata Masahiro、Kataoka Tatsuki R.、Hiramatsu Hidefumi、Yasumi Takahiro、Nakahata Tatsutoshi、Imai Yoichi、Takita Junko、Adachi Souichi、Sugiyama Hiroshi、Kamikubo Yasuhiko
- Journal Title
  
  eJHaem
  
  Volume: 2 Issue: 3 Pages: 449-458
- DOI
  10.1002/jha2.230
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20H05667
[Journal Article] Small-molecule HDAC and Akt inhibitors suppress tumor growth and enhance immunotherapy in multiple myeloma2021
- Author(s)
  Hirano Mitsuhito、Imai Yoichi、Kaito Yuta、Murayama Takahiko、Sato Kota、Ishida Tadao、Yamamoto Junichi、Ito Takumi、Futami Muneyoshi、Ri Masaki、Yasui Hiroshi、Denda Tamami、Tanaka Yukihisa、Ota Yasunori、Nojima Masanori、Kamikubo Yasuhiko、Gotoh Noriko、Iida Shinsuke、Handa Hiroshi、Tojo Arinobu
- Journal Title
  
  Journal of Experimental & Clinical Cancer Research
  
  Volume: 40 Issue: 1 Pages: 110-110
- DOI
  10.1186/s13046-021-01909-7
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20H05667, KAKENHI-PROJECT-18H02679, KAKENHI-PROJECT-19K22557, KAKENHI-PUBLICLY-20H05029, KAKENHI-PROJECT-21H02761, KAKENHI-PROJECT-20K08726
[Journal Article] Association between thiamine decrease and neuropsychiatric symptoms in gastrointestinal and hematological cancer patients receiving chemotherapy2021
- Author(s)
  Iimura Yohei、Kurokawa Tomohiro、Andoh Shohei、Kanemoto Yoshiaki、Kawamata Toyotaka、Yazawa Kentaro、Sato Aki、Yokoyama Kazuaki、Imai Yoichi、Tsurita Giichiro、Ahiko Yuka、Aikou Susumu、Shida Dai、Nojima Masanori、Tojo Arinobu、Sugiura Munetoshi、Kuroda Seiichiro
- Journal Title
  
  Biomedicine and Pharmacotherapy
  
  Volume: 141 Pages: 111929-111929
- DOI
  10.1016/j.biopha.2021.111929
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20H05667
[Journal Article] Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapse2021
- Author(s)
  Yasui Hiroshi、Kobayashi Masayuki、Sato Kota、Kondoh Kanya、Ishida Tadao、Kaito Yuta、Tamura Hideto、Handa Hiroshi、Tsukune Yutaka、Sasaki Makoto、Komatsu Norio、Tanaka Norina、Tanaka Junji、Kizaki Masahiro、Kawamata Toyotaka、Makiyama Junya、Yokoyama Kazuaki、Imoto Seiya、Tojo Arinobu、Imai Yoichi
- Journal Title
  
  International Journal of Clinical Oncology
  
  Volume: 26 Issue: 11 Pages: 2142-2150
- DOI
  10.1007/s10147-021-01991-z
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20H05667, KAKENHI-PROJECT-20K08726
[Journal Article] Prognostic impacts of peripheral blood erythroblasts after single‐unit cord blood transplantation2021
- Author(s)
  Kaito Yuta、Konuma Takaaki、Monna‐Oiwa Maki、Kato Seiko、Isobe Masamichi、Okabe Motohito、Imai Yoichi、Takahashi Satoshi、Tojo Arinobu
- Journal Title
  
  International Journal of Laboratory Hematology
  
  Volume: 43 Issue: 6 Pages: 1437-1442
- DOI
  10.1111/ijlh.13622
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20H05667, KAKENHI-PROJECT-20K08748
[Journal Article] Thiamine Deficiency and Neurological Symptoms in Patients with Hematological Cancer Receiving Chemotherapy: A Retrospective Analysis2021
- Author(s)
  Iimura Yohei、Andoh Shohei、Kawamata Toyotaka、Sato Aki、Yokoyama Kazuaki、Imai Yoichi、Tojo Arinobu、Nojima Masanori、Sugiura Munetoshi、Kuroda Seiichiro
- Journal Title
  
  Journal of Neurosciences in Rural Practice
  
  Volume: 12 Pages: 726-732
- DOI
  10.1055/s-0041-1735825
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20H05667
[Journal Article] SLAMF3-mediated signaling via ERK pathway activation promotes aggressive myeloma behaviors in multiple myeloma.2020
- Author(s)
  Ishibashi M, Takahashi R, Tsubota A, Sasaki M, Handa H, Imai Y, Tanaka N, Tsukune Y, Tanosaki S, Ito S, Asayama T, Sunakawa M, Kaito Y, Kuribayashi-Hamada Y, Kondo-Onodera A, Moriya K, Komatsu N, Tanaka J, Odajima T, Sugimori H, Inokuchi K, and Tamura H.
- Journal Title
  
  Molecular Cancer Research
  
  Volume: 18 Issue: 4 Pages: 632-643
- DOI
  10.1158/1541-7786.mcr-19-0391
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09916, KAKENHI-PROJECT-17K16196
[Journal Article] Latest Development in Multiple Myeloma2020
- Author(s)
  Imai Yoichi
- Journal Title
  
  Cancers
  
  Volume: 12 Issue: 9 Pages: 2544-2544
- DOI
  10.3390/cancers12092544
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08726, KAKENHI-PROJECT-20H05667
[Journal Article] Notch1&JAG1 signaling induces aggressive myeloma cell behaviors.2020
- Author(s)
  Ishibashi M, Ueda K, Imai Y, Inokuchi K, Morita R, Tamura H.
- Journal Title
  
  International Journal of Myeloma
  
  Volume: 9 Pages: 1-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09916
[Journal Article] Fractionated ifosfamide, carboplatin, and etoposide with rituximab as a safe and effective treatment for relapsed/refractory diffuse large B cell lymphoma with severe comorbidities2020
- Author(s)
  Tanaka Norina、Imai Yoichi、Yoshinaga Kentaro、Shiseki Masayuki、Tanaka Junji
- Journal Title
  
  Annals of Hematology
  
  Volume: 99 Issue: 11 Pages: 2577-2586
- DOI
  10.1007/s00277-020-04267-0
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K08726
[Journal Article] HDAC inhibitors exert anti-myeloma effects through multiple modes of action.2019
- Author(s)
  Imai Y, Hirano M, Kobayashi M, Futami M, and Tojo A.
- Journal Title
  
  Cancers
  
  Volume: 11 Issue: 4 Pages: 475-489
- DOI
  10.3390/cancers11040475
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09916
[Journal Article] Safety of lenalidomide, dexamethasone, and cyclophosphamide in elderly Japanese patients with relapsed and refractory multiple myeloma: results of phase 1 study.2019
- Author(s)
  Tsukune Y, Sasaki M, Isoda A, Ando J, Koike M, Matsumoto M, Sawamura M, Tamura H, Handa H, Imai Y, Yahata Y, and Komatsu N.
- Journal Title
  
  International Journal of Myeloma
  
  Volume: 9 Pages: 1-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09916
[Journal Article] Nested polymerase chain reaction with specific primers for Mucorales in the serum of patients with hematological malignancies.2019
- Author(s)
  Hirano M, Ota Y, Koibuchi T, Takei T, Takeda R, Kawamata T, Yokoyama K, Uchimaru K, Yotsuyanagi H, Imai Y, Tojo A.
- Journal Title
  
  The Japanese Journal of Infectious Diseases
  
  Volume: 印刷中
- NAID
  130007652445
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09916
[Journal Article] Clinical impact of serum soluble SLAMF7 in multiple myeloma.2018
- Author(s)
  Ishibashi M, Soeda S, Sasaki M, Hand H, Imai Y, Tanaka N, Tanosaki S, Ito S, Odajima T, Sugimori H, Asayama T, Sunakawa M, Kaito Y, Kinoshita R, Kuribayashi Y, Onodera A, Moriya K, Tanaka J, Tsukune Y, Komatsu N, Inokuchi K and Tamura H.
- Journal Title
  
  Oncotarget
  
  Volume: 9 Pages: 34784-34793
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09916
[Journal Article] Nonmyelomatous ascites resulting from the increased secretion of vascular endothelial growth factor in multiple myeloma.2017
- Author(s)
  Maki H, Nannya Y, Imai Y, Yamaguchi S, Kamikubo Y, Ichikawa M, Nakamura F, Kurokawa M.
- Journal Title
  
  Intern Med
  
  Volume: -
- NAID
  130006407675
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09916
[Journal Article] Chronic inflammatory demyelinating polyneuropathy in adult T-cell leukemia-lymphoma patients following allogeneic stem cell transplantation.2017
- Author(s)
  Hirano M, Jimbo K, Ogawa M, Ochi K, Makiyama J, Kawamata T, Yokoyama K, Tanaka T, Inamoto Y, Yamano Y, Fukuda T, Uchimaru K, Imai Y, Tojo A.
- Journal Title
  
  Bone Marrow Transplantation
  
  Volume: -
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09916
[Journal Article] Hypersensitivity reaction to beta-lactam antibiotics in patients with adult T-cell leukemia/lymphoma treated with mogamulizumab.2017
- Author(s)
  Yasu T, Imai Y, Ohno N, Uchimaru K, Kurokawa Y, Tojo A.
- Journal Title
  
  Int J Clin Pharmacol Ther
  
  Volume: -
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09916
[Journal Article] Secondary syphilis with tonsillar and cervical lymphadenopathy and a pulmonary lesion mimicking malignant lymphoma.2017
- Author(s)
  Komeno Y, Ota Y, Koibuchi T, Imai Y, Iihara K, Ryu T.
- Journal Title
  
  Am J Case Rep
  
  Volume: -
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09916
[Journal Article] Knockdown of the Wnt receptor Frizzled-1 (FZD1) reduces MDR1/P-glycoprotein expression in multidrug resistant leukemic cells and inhibits leukemic cell proliferation.2017
- Author(s)
  Wang YH, Imai Y, Shiseki M, Tanaka J, Motoji T.
- Journal Title
  
  Leuk Res
  
  Volume: -
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09916
[Journal Article] Different clonal evolution of chronic myeloid leukemia between bone marrow and the central nervous system.2017
- Author(s)
  Ogawa M, Yokoyama K, Hirano M, Jimbo K, Ochi K, Kawamata T, Ohno N, Shimizu E, Yokoyama N, Yamaguchi R, Imoto S, Uchimaru K, Miyano S, Imai Y*, Tojo A.
- Journal Title
  
  Br J Haematol
  
  Volume: -
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09916
[Journal Article] A case report of donor cell-derived leukemia after cord blood transplantation and a review of the literature : differences from bone marrow as the transplanted source2014
- Author(s)
  Shiozaki H, Yoshinaga K, Kondo T, Imai Y, Shiseki M, Mori N, Teramura M, Motoji T
- Journal Title
  
  Bone Marrow Transplantation
  
  Volume: 49 Pages: 102-109
- Data Source
  KAKENHI-PROJECT-23591409
[Journal Article] Identification of calcineurin as a novel therapeutic target in multiple myeloma2013
- Author(s)
  Imai Y, Ohta E, Wang Y, Kitagawa Y, Ding Y, Yamada O, Maru Y, Motoji T
- Journal Title
  
  Clinical Lymphoma, Myeloma, & Leukemia
  
  Volume: 13
- Data Source
  KAKENHI-PROJECT-23591409
[Journal Article] Identification of calcineurin as a novel therapeutic target in multiple myeloma.2013
- Author(s)
  Imai Y, Ohta E, Wang Y, Kitagawa Y, Ding Y, Yamada O, Maru Y, Motoji T
- Journal Title
  
  Clinical Lymphoma, Myeloma, & Leukemia
  
  Volume: 13 supplement 1 Pages: 47-47
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591409
[Journal Article] Transient lupus anticoagulant with a prolonged activated partial thromboplastin time secondary to cytomegalovirus-related infectious mononucleosis2013
- Author(s)
  Shimura H, Imai Y, Ieko M, Shiseki M, Mori N, Teramura M, Motoji T
- Journal Title
  
  Annals of Hematology
  
  Volume: 2 Pages: 143-144
- Data Source
  KAKENHI-PROJECT-23591409
[Journal Article] Multiple phosphorylation sites are important for RUNX1 activity in early hematopoiesis and T-cell differentiation2012
- Author(s)
  Yoshimi M, Goyama S, Kawazu M, Nakagawa M, Ichikawa M, Imai Y, Kumano K, Asai T, Mulloy JC, Kraft AS, Takahashi T, Shirafuji N, Kurokawa M
- Journal Title
  
  European Journal of Immunology
  
  Volume: 42 Pages: 1044-1050
- Data Source
  KAKENHI-PROJECT-23591409
[Journal Article] MLL-HOXA9 and calcineurin are novel therapeutic targets in multiple myeloma2012
- Author(s)
  Imai Y, Ohta E, Wang Y, Kitagawa Y, Ding Y, Yamada O, Maru Y, Motoji T
- Journal Title
  
  American Society of Hematology annual meeting abstracts
  
  Volume: 120 Pages: 4007-4007
- Data Source
  KAKENHI-PROJECT-23591409
[Journal Article] Combined romiplostim and intravenous immunoglobulin therapy increased platelet count, facilitating splenectomy in a patient with refractory immune thrombocytopenic purpura unresponsive to monotherapy2012
- Author(s)
  Mitsuhashi K, Ishiyama M, Imai Y, Shiseki M, Mori N, Teramura M, Seshimo A, Motoji T
- Journal Title
  
  British Journal of Haematology
  
  Volume: 158 Pages: 798-800
- Data Source
  KAKENHI-PROJECT-23591409
[Journal Article] The effect of iron overload and chelation on erythroid differentiation2012
- Author(s)
  Taoka K, Kumano K, Nakamura F, Hosoi M, Goyama S, Imai Y, Hangaishi A, Kurokawa M
- Journal Title
  
  International Journal of Hematology
  
  Volume: 95 Pages: 149-159
- NAID
  10030267276
- Data Source
  KAKENHI-PROJECT-23591409
[Journal Article] Loss of AML1/Runx1 accelerates the development of MLL-ENL leukemia through downregulation of p19ARF2011
- Author(s)
  黒川峰夫, 他
- Journal Title
  
  Blood
  
  Volume: 118 Issue: 9 Pages: 2541-2550
- DOI
  10.1182/blood-2010-10-315440
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19679004, KAKENHI-PROJECT-22790901, KAKENHI-PUBLICLY-23130503, KAKENHI-PROJECT-23591369, KAKENHI-PROJECT-23591409
[Journal Article] Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins2011
- Author(s)
  Yoshimi A, Goyama S, Watanabe-Okochi N, Yoshiki Y, Nannya Y, Nitta E, Arai S, Sato T, Shimabe M, Nakagawa M, Imai Y, Kitamura T, Kurokawa M
- Journal Title
  
  Blood
  
  Volume: 117 Pages: 3617-3628
- Data Source
  KAKENHI-PROJECT-23591409
[Journal Article] Loss of AML1/Runx1 accelerates the development of MLL-ENL leukemia through down-regulation of p19^<ARF>2011
- Author(s)
  Nishimoto N, Arai S, Ichikawa M, Nakagawa M, Goyama S, Kumano K, Takahashi T, Kamikubo Y, Imai Y, Kurokawa M
- Journal Title
  
  Blood
  
  Volume: 118 Pages: 2541-2550
- Data Source
  KAKENHI-PROJECT-23591409
[Journal Article] AML1/RUNX1 functions as a cytoplasmic attenuator of NF-κB signaling in the repression of myeloid tumors2011
- Author(s)
  Masahiro Nakagawa
- Journal Title
  
  Blood
  
  Volume: 118 Issue: 25 Pages: 6626-6637
- DOI
  10.1182/blood-2010-12-326710
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-09J04996, KAKENHI-PROJECT-19679004, KAKENHI-PROJECT-22790901, KAKENHI-PUBLICLY-23130503, KAKENHI-PROJECT-23591369, KAKENHI-PROJECT-23591409
[Journal Article] Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activity2011
- Author(s)
  Kataoka K, Sato T, Yoshimi A, Goyama S, Tsuruta T, Kobayashi H, Shimabe M, Arai S, Nakagawa M, Imai Y, Kumano K, Kumagai K, Kubota, N, Kadowaki T, Kurokawa M
- Journal Title
  
  Journal of Experimental Medicine
  
  Volume: 208 Pages: 2403-2416
- Data Source
  KAKENHI-PROJECT-23591409
[Journal Article] The negative impact of female donor/male recipient combination in allogeneic hematopoietic stem cell transplantation depends on disease risk2011
- Author(s)
  Nannya Y, Kataoka K, Hangaishi A, Imai Y, Takahashi T, Kurokawa M
- Journal Title
  
  Transplant International
  
  Volume: 24 Pages: 469-476
- Data Source
  KAKENHI-PROJECT-23591409
[Journal Article] AML1/RUNX1 functions as a cytoplasmic attenuator of NF-kB signaling in the repression of myeloid tumors2011
- Author(s)
  Nakagawa M, Shimabe M, Watanabe-Okochi N, Arai S, Yoshimi A, Shinohara A, Nishimoto N, Kataoka K, Sato T, Kumano K, Nannya Y, Ichikawa M, Imai Y, Kurokawa M
- Journal Title
  
  Blood
  
  Volume: 118 Pages: 6626-6637
- Data Source
  KAKENHI-PROJECT-23591409
[Journal Article] Evi-1 is a transcriptional target of mixed-lineage leukemia oncoproteins in hematopoietic stem cells2011
- Author(s)
  Arai S, Yoshimi A, Shimabe M, Ichikawa M, Nakagawa M, Imai Y, Goyama S, Kurokawa M
- Journal Title
  
  Blood
  
  Volume: 117 Pages: 6304-6314
- Data Source
  KAKENHI-PROJECT-23591409
[Presentation] Immune Checkpoint Molecule Signaling and Immunotherapy in Myeloma2023
- Author(s)
  Hideto Tamura, Mariko Ishibashi, Yoichi Imai
- Organizer
  the 13th Japanese Society of Hematology (JSH) International Symposium
- Invited
- Data Source
  KAKENHI-PROJECT-20H05667
[Presentation] Strategy for maintenance therapy for transplant-eligible and non-eligible patients with multiple myeloma in JAPAN. Symposium title: Optimizing MM Maintenance Management with Oral Proteasome Inhibitor.2023
- Author(s)
  Yoichi Imai
- Organizer
  TSH (Thailand Society of Hematology) -IS Bangkok 2023 (8th International Symposium and 61st Annual Meeting of TSH), バンコク
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20H05667
[Presentation] 多発性骨髄腫の免疫療法―既存抗体の作用メカニズム・治療成績からCAR-T細胞療法、bispecific antibodyの現状・開発状況までシンポジウム1骨髄腫治療の限界の打破を目指して　免疫療法の新展開2023
- Author(s)
  今井　陽一
- Organizer
  第48回日本骨髄腫学会学術集会, 東京, 2023, 5
- Invited
- Data Source
  KAKENHI-PROJECT-20H05667
[Presentation] 多発性骨髄腫における免疫療法の基礎と臨床―新規治療も含めてMechanism of action and clinical results of immunotherapy for multiple myeloma.2022
- Author(s)
  今井　陽一
- Organizer
  第84回日本血液学会学術集会　教育講演
- Invited
- Data Source
  KAKENHI-PROJECT-20K08726
[Presentation] DNAM-1/TIGIT/CD155/CD112 Axis Is a Novel Target of NK-Cell Therapy in Acute Myeloid Leukemia.2022
- Author(s)
  Kaito Y, Sugimoto E, Nakamura F, Tsukune Y, Sasaki, Yui S, Yamaguchi H, Goyama S, Nannya Y, Mitani K, Tamura H, Imai Y.
- Organizer
  64th American Society of Hematology Annual meeting
- Data Source
  KAKENHI-PROJECT-20K08726
[Presentation] DNAM-1/TIGIT/CD155/CD112 Axis Is a Novel Target of NK-Cell Therapy in Acute Myeloid Leukemia.2022
- Author(s)
  Kaito Y, Sugimoto E, Nakamura F, Tsukune Y, Sasaki, Yui S, Yamaguchi H, Goyama S, Nannya Y, Mitani K, Tamura H, Imai Y.
- Organizer
  64th American Society of Hematology Annual meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20H05667
[Presentation] Bench-to-clinical research accelerated by Future PET Development Unit2022
- Author(s)
  Taiga Yamaya, Miwako Takahashi, Hideaki Tashima, Go Akamatsu, Sodai Takyu, Eiji Yoshida, Shunsuke Kurosawa, Hideaki Haneishi, Mikio Suga, Kazuya Kawamura, Yoichi Imai
- Organizer
  第124回日本医学物理学会学術大会
- Data Source
  KAKENHI-PROJECT-20H05667
[Presentation] 未来PET創造研究ユニットが推進するB-to-C研究：頭部から全身へ2022
- Author(s)
  山谷泰賀, 高橋美和子, 田島英朗, 赤松剛, 田久創大, 吉田英治, 黒澤俊介, 鎌田圭, 吉川彰, 羽石秀昭, 菅幹生, 川村和也, 石橋真理子, 今井陽一
- Organizer
  第83回応用物理学会秋季学術講演会
- Data Source
  KAKENHI-PROJECT-20H05667
[Presentation] 多発性骨髄腫における免疫療法の基礎と臨床―新規治療も含めてMechanism of action and clinical results of immunotherapy for multiple myeloma.2022
- Author(s)
  今井　陽一
- Organizer
  第84回日本血液学会学術集会　教育講演
- Invited
- Data Source
  KAKENHI-PROJECT-20H05667
[Presentation] 進化する多発性骨髄腫の診断と治療2022
- Author(s)
  今井　陽一
- Organizer
  第4回日本血液学会関東甲信越地方会若手教育セミナー
- Invited
- Data Source
  KAKENHI-PROJECT-20H05667
[Presentation] 再発・難治多発性骨髄腫に対するBCMA標的療法の作用機序と臨床成績 / Action mechanisms of BCMA -targeted therapies for multiple myeloma and their promising and exciting clinical results in relapse/refractory patients. Recent advances in targeted therapy for B-cell malignancies.2022
- Author(s)
  今井　陽一
- Organizer
  第19回日本臨床腫瘍学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-20K08726
[Presentation] 急性リンパ性白血病移植後における腫瘍由来循環DNAの有用性2021
- Author(s)
  小川弥穂、横山和明、高橋華、伊藤美香、遊佐希、清水英悟、片山琴絵、岡部基人、磯部優理、小沼貴晶、今井陽一、井元清哉、高橋聡
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-20H05667
[Presentation] Rag2欠損マウスの高活性NK細胞が急性骨髄性白血病の発症を抑制する2021
- Author(s)
  杉本絵美、合山進、浅田修平、海渡裕太、今井陽一、福山朋房、田中洋介、北村俊雄
- Organizer
  第80回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-20H05667
[Presentation] 再発・難治多発性骨髄腫に対するBCMA標的療法の作用機序と臨床成績2021
- Author(s)
  今井陽一
- Organizer
  第19回日本臨床腫瘍学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-20H05667
[Presentation] 急性骨髄性白血病に対する改変NK細胞療法の検討2021
- Author(s)
  海渡裕太、杉本絵美、合山進、田中淳司、田村秀人、今井陽一
- Organizer
  第80回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-20K08726
[Presentation] 急性骨髄性白血病に対する免疫チェックポイント改変NK細胞療法2021
- Author(s)
  海渡裕太、平野光人、二見宗孔、杉本絵美、合山進、王艶華、田中淳司、田村秀人、東條有伸、今井陽一
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-20K08726
[Presentation] Hyperactive NK cells in Rag2-deficient mice suppress the development of acute myeloid leukemia2021
- Author(s)
  Emi Sugimoto, Susumu Goyama, Shuhei Asada, Yuta Kaito, Yoichi Imai, Tomofusa Fukuyama, Yosuke Tanaka, Toshio Kitamura
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-20H05667
[Presentation] 急性骨髄性白血病に対する免疫チェックポイント改変NK細胞療法2021
- Author(s)
  海渡裕太、平野光人、二見宗孔、杉本絵美、合山進、王艶華、田中淳司、田村秀人、東條有伸、今井陽一
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-20H05667
[Presentation] 急性骨髄性白血病に対する改変NK細胞療法の検討2021
- Author(s)
  海渡裕太、杉本絵美、合山進、田中淳司、田村秀人、今井陽一
- Organizer
  第80回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-20H05667
[Presentation] HDAC阻害薬とAKT阻害薬は多発性骨髄腫に対して増殖を抑制し腫瘍免疫を賦活化する2020
- Author(s)
  平野光人、今井陽一、村山貴彦、佐藤広太、山本淳一、伊藤拓水、二見宗孔、李政樹、安井寛、上久保靖彦、後藤典子、石田禎夫、飯田真介、半田宏、東條有伸
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-20K08726
[Presentation] 多発性骨髄腫における活性型インテグリンb7の発現の解析2020
- Author(s)
  保仙直毅、吉原哲、高松博幸、李政樹、永田泰之、小杉浩史、下村良充、花村一朗、藤重夫、皆内康一郎、黒田純也、鈴木利貴央、西村倫子、魚嶋伸彦、中前博久、河野和、水野石一、五明広志、鈴木憲史、尾崎修治、中村信元、今井陽一、木崎昌弘、根来英樹、半田寛、飯田真介
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-20H05667
[Presentation] HDAC阻害薬とAKT阻害薬は多発性骨髄腫に対して増殖を抑制し腫瘍免疫を賦活化する2020
- Author(s)
  平野光人、今井陽一、村山貴彦、佐藤広太、山本淳一、伊藤拓水、二見宗孔、李政樹、安井寛、上久保靖彦、後藤典子、石田禎夫、飯田真介、半田宏、東條有伸
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-20H05667
[Presentation] 抗体医薬の進歩～ADC(抗体薬物複合体)、二重特異性(BiTE)抗体まで～2020
- Author(s)
  今井　陽一
- Organizer
  第58回日本癌治療学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-20H05667
[Presentation] AMLにおける免疫チェックポイント分子CD155/CD112を標的としたFLT3阻害療法の可能性2020
- Author(s)
  海渡裕太、平野光人、二見宗孔、田村秀人、東條有伸、今井陽一
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-20K08726
[Presentation] Combined Inhibition of HDAC and AKT As a Strategy to Overcome Multi-Drug Resistance in Patients with Multiple Myeloma.2019
- Author(s)
  Hirano H, Imai Y, Murayama T, Sato K, Yamamoto J, Takumi Ito, Futami M, Ri M, Yasui H, Gotoh N, Iida S, Ishida T, Handa H, Tojo A.
- Organizer
  61th American Society of Hematology Annual meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09916
[Presentation] 薬剤抵抗性多発性骨髄腫に対する新規戦略としてのHDAC阻害薬とAKT阻害薬2019
- Author(s)
  平野　光人、今井　陽一、村山　貴彦、佐藤　広太、山本　淳一、二見　宗孔、李　政樹、伊藤　拓水、安井　寛、後藤　典子、飯田　真介、半田　宏、東條　有伸
- Organizer
  第81回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-17K09916
[Presentation] Combined HDAC and AKT inhibition as a strategy to overcome multi-drug resistant multiple myeloma.2019
- Author(s)
  Imai Y
- Organizer
  4th SNU BIO symposium, 26th East Asia Joint Symposium on Biomedical Research
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09916
[Presentation] 骨髄腫治療におけるHDAC阻害による細胞内シグナル阻害と腫瘍免疫賦活化2018
- Author(s)
  今井　陽一、平野光人、佐藤広太、二見宗孔、東條有伸
- Organizer
  日本骨髄腫学会学術集会シンポジウム
- Invited
- Data Source
  KAKENHI-PROJECT-17K09916
[Presentation] HDAC and AKT inhibitors enhance anti-myeloma effects of daratumumab.2018
- Author(s)
  Mitsuhito Hirano, Yoichi Imai, Wengchif Ung, Kota Sato, Muneyoshi Futami, Arinobu Tojo.
- Organizer
  第80回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-17K09916
[Presentation] HDAC and AKT inhibitors enhance anti-myeloma effects of dartumumab.2018
- Author(s)
  平野　光人、今井　陽一、二見　宗孔、東條　有伸
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17K09916
[Presentation] Histone Deacetylase Inhibitors with or without AKT Inhibition Potentially Increase the Efficacy of Daratumumab in Multiple Myeloma By Enhancing the Antibody-Dependent Cell-Mediated and Complement-Dependent Cytotoxicity As Well As Apoptosis.2018
- Author(s)
  Hirano M, Imai Y, Ung WC, Sato K, Futami M and Tojo A.
- Organizer
  0th American Society of Hematology Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09916
[Presentation] A Novel Mutant WASp in X-linked Neutropenia Partially Recapitulates Defective Neutrophil Production through its Expression in WASP-deficient NB4 Cells.2017
- Author(s)
  Kobayashi M, Chanda B, Futami M, Yamashita M, Hirano M, Yokoyama K, Imai Y, Shimizu E, Yusa N, Yamaguchi R, Imoto S, Miyano S, Tojo A.
- Organizer
  The 59th Annual Meeting of American Society of Hematology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09916
[Presentation] Viral infections in acute myeloid leukemia accompanied with adult T-cell leukemia/lymphoma.2017
- Author(s)
  Jimbo K, Imai Y, Ogawa M, Hirano M, Ochi K, Kawamata T, Yokoyama K, Yasui H, Ohno N, Uchimaru K, Tojo A.
- Organizer
  第79回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-17K09916
[Presentation] Chronic inflammatory demyelinating polyneuropathy in ATL patients after allo-SCT.2017
- Author(s)
  Hirano M, Imai Y, Jimbo K, Ogawa M, Ochi K, Kawamata T, Yokoyama K, Ohno N, Yamano Y, Fukuda T, Uchimaru K, Tojo A.
- Organizer
  第79回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-17K09916
[Presentation] ATL患者の同種造血幹細胞移植後に慢性炎症性脱髄性多発ニューロパチーを発症した3症例の解析2017
- Author(s)
  平野　光人、今井　陽一、神保　光児、小川　弥穂、越智　清純、川俣　豊隆、横山　和明、大野　伸広、山野　嘉久、福田　隆浩、内丸　薫、東條　有伸
- Organizer
  第4回日本HTLV-1学会学術集会
- Data Source
  KAKENHI-PROJECT-17K09916
[Presentation] The new immunoreceptor SLAMF3 promotes aggressive biological and clinical characteristics in multiple myeloma.2017
- Author(s)
  Ishibashi M, Tamura H, Asayama T, Kuribayashi-hamada Y, Onodera A, Moriya K, Sasaki M, Handa H, Imai Y, Tanaka N, Tanaka J, Tanosaki S, Ito S, Komatsu N, Inokuchi K.
- Organizer
  The 59th Annual Meeting of American Society of Hematology, 2017
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09916
[Presentation] Identification of Calcineurin as a Novel Therapeutic Target in Multiple Myeloma2013
- Author(s)
  Yoichi Imai, Eri Ohta, Yanhua Wang, Yukiko Kitagawa, Ye Ding, Osamu Yamda, Yoshiro Maru, and Toshiko Motoji
- Organizer
  14th International Myeloma　Ｗｏｒｋｓｈｏｐ
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-23591409
[Presentation] Identification of calcineurin as a novel therapeutic target in multiple myeloma2013
- Author(s)
  Imai Y, Ohta E, Wang Y, Kitagawa Y, Ding Y, Yamada O, Maru Y, Motoji T
- Organizer
  14th International Myeloma Workshop
- Place of Presentation
  Kyoto
- Year and Date
  2013-04-04
- Data Source
  KAKENHI-PROJECT-23591409
[Presentation] Identification of calcineurin as a novel therapeutic target in multiple myeloma.2013
- Author(s)
  Imai Y, Ohta E, Wang Y, Kitagawa Y, Ding Y, Yamada O, Maru Y, Motoji T
- Organizer
  14th International Myeloma Workshop
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-23591409
[Presentation] MLK-HOXA9 and Calcineurin are Novel Therapeutic Targets in Multiple Myeloma2012
- Author(s)
  Yoichi Imai, Eri Ohta, Yanhua Wang, Yukiko Kitagawa, Ye Ding, Osamu Yamda, Yoshiro Maru, and Toshiko Motoji
- Organizer
  アメリカ血液学会総会
- Place of Presentation
  米国、アトランタ
- Data Source
  KAKENHI-PROJECT-23591409
[Presentation] MLL is a novel target of anti-myeloma therapy and it is degraded by inhibitors of histone deacetylase (HDAC) and HSP90.2012
- Author(s)
  Yoichi Imai, Eri Ohta, Yanhua Wang, Ye Ding, Osamu Yamada, Yoshiro Maru, and Toshiko Motoji
- Organizer
  日本血液学会総会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-23591409
[Presentation] Elucidation of MLL as a novel therapy target and molecular mechanism of inhibitors of HDAC and HSP90 in multiple myeloma2012
- Author(s)
  Yoichi Imai, Eri Ohta, Yanhua Wang, Ye Ding, Osamu Yamda, Yoshiro Maru, and Toshiko Motoji
- Organizer
  日本骨髄腫学会総会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-23591409
[Presentation] MLL-HOXA9 and calcineurin are novel therapeutic targets in multiple myeloma2012
- Author(s)
  Imai Y, Ohta E, Wang Y, Kitagawa Y, Ding Y, Yamada O, Maru Y, Motoji T
- Organizer
  54th American Society of Hematology Annual Meeting
- Place of Presentation
  Atlanta, December
- Data Source
  KAKENHI-PROJECT-23591409

1. 山谷泰賀 (40392245)

# of Collaborated Projects: 2 results

# of Collaborated Products: 2 results
2. 吉川彰 (50292264)

# of Collaborated Projects: 2 results

# of Collaborated Products: 1 results
3. 菅幹生 (00294281)

# of Collaborated Projects: 2 results

# of Collaborated Products: 2 results
4. 永津弘太郎 (30531529)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
5. 高橋美和子 (00529183)

# of Collaborated Projects: 2 results

# of Collaborated Products: 5 results
6. 吉田英治 (50392246)

# of Collaborated Projects: 2 results

# of Collaborated Products: 2 results
7. 田島英朗 (70572907)

# of Collaborated Projects: 2 results

# of Collaborated Products: 2 results
8. MARU Yoshiro (00251447)

# of Collaborated Projects: 1 results

# of Collaborated Products: 10 results
9. 安井寛 (40448593)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
10. 石橋真理子 (20599047)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
11. 合山進 (80431849)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
12. 松尾英将

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
13. 黒川峰夫

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Imai Yoichi 今井 陽一

IMAI YOICHI 今井 陽一

IMAI Yoichi 今井 陽一

今井 陽一 イマイ ヨウイチ

Research Projects

Research Products

Co-Researchers

DNAM-1/TIGIT/CD155/CD112を標的としたAMLに対する免疫療法の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Strategy to overcome the refractoriness of hematological malignancies through inhibition of intracellular signaling and immune enhancementPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Whole gamma imaging to break through the physical limitation of positron emission tomography

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Zr-89 PETの物理限界を克服する全ガンマ線イメージング法の開発

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Optimization of treatment for multiple myeloma with HDAC inhibitorsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Molecular mechanism of refractoriness of myeloma mediated by adhesion moleculesPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

プロテオミクスによる白血病関連転写因子AML1の機能制御機構の網羅的解析Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] 多発性骨髄腫の診療指針 第5版 日本骨髄腫学会編 IV治療 6維持療法2020

Author(s)

Total Pages

Publisher

ISBN

Data Source

[Book] Heat Shock Proteins in Signaling Pathways, Heat Shock Proteins 172019

Author(s)

Total Pages

Publisher

Data Source

[Book] 多発性骨髄腫発生病理とmixed-lineage leukemia (MLL)タンパク2014

Author(s)

Publisher

Data Source

[Book] 症例から学ぶメディカルオンコロジー2011

Author(s)

Total Pages

Publisher

Data Source

[Journal Article] Hyperactive Natural Killer cells in Rag2 knockout mice inhibit the development of acute myeloid leukemia2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Progression to B acute lymphoblastic leukemia in 8p11 myeloproliferative syndrome with t(6;8)(q27;p12)2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Serum soluble CD86 levels correlate with CD86 variant 3 gene expression and are prognostic indicators in myeloma2023

Imai Yoichi 今井陽一

IMAI YOICHI 今井陽一

IMAI Yoichi 今井陽一

今井陽一イマイヨウイチ

[Book] 多発性骨髄腫の診療指針　第5版　日本骨髄腫学会編　IV治療　6維持療法2020